今日港股医药股震荡走高,成分股三生制药涨13%,创2021年6月以来新高,威高股份、信达生物分别涨12.75%和10.76%,带动香港医药ETF(513700)盘中大涨3.95%,年内涨幅扩大至22%。消息面上主要是2024年业绩披露情况较好, 三生制药2024年盈利约20.9亿元,同比增长34.9%;信达生物毛利约 79.12 亿元,同比增长 56.1%,年内亏损同比收窄 90.8%。威高股份...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.